Cite

HARVARD Citation

    Carlevato, R. et al. (n.d.). PH-0499 SABR as a treatment option for HCC patients: efficacy and toxicity profile. Radiotherapy and oncology. pp. S381-S382. [Online]. 
  
Back to record